MedTrace Logo

Monitoring and Evaluation Study of Project ECHO for ILD

NCT05455437 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-07-13

No results posted yet for this study

Summary

The study will utilize pre-post survey measures to evaluate Project ECHO for ILD with respect to an initial set of practice and clinical outcomes and relies on questionnaire data obtained from providers participating in Project ECHO for ILD at baseline, at 6 months, and at study end.

Conditions

  • Interstitial Lung Diseases

Sponsors & Collaborators

  • Genentech, Inc.

    collaborator INDUSTRY

  • Pulmonary Care and Research Collaborative Limited

    lead OTHER

Principal Investigators

  • Aliaa Barakat, PhD · Pulmonary Care and Research Collaborative, Ltd.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-31
Primary Completion
2023-12-31
Completion
2024-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05455437 on ClinicalTrials.gov